← Eichor
Condition: Hemophilia A Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Hemophilia A

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study to Test a Medicine (Fitusiran) for Preventing Bleeds in People With Severe Hemophilia Who Previously Received Pr
Phase 4 · 2 location(s) · Sanofi · NCT06145373Efficacy, Safety & Utilisation of Nuwiq, Octanate and Wilate in Previously Untreated & Minimally Treated Haemophilia A P
Phase N/A · 59 location(s) · Octapharma · NCT03695978A Study to Investigate the Safety and Effectiveness of a Coagulation Factor IX Gene Insertion Therapy (REGV131-LNP1265)
Phase 1/Phase 2 · 44 location(s) · Regeneron Pharmaceuticals · NCT06379789A Clinical Study to Evaluate the Effects of NXT007 Compared to Factor VIII Prophylaxis in Participants With Hemophilia A
Phase 3 · 2 location(s) · Hoffmann-La Roche · NCT07416526Gene Therapy for Chinese Hemophilia A
NA · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT04728841Global Haemostatic Methods Following Administration of Bypassing Agents to Patients With Haemophilia With Inhibitors
Phase N/A · 1 location(s) · Karolinska Institutet · NCT02453542World Bleeding Disorders Registry
Phase N/A · 1 location(s) · World Federation of Hemophilia · NCT03327779ITI Using SCT800 Alone or Combining Daratumumab in Hemophilia A Adolescents and Adults With High Titer Inhibitor
Phase 4 · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT05888870The Efficacy and Safety of ZS801 in Chinese Hemophilia B Patients.
NA · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT05630651Monitoring of Anti-TFPI in Hemophilia
Phase N/A · 2 location(s) · Hospices Civils de Lyon · NCT07101926Development of Non-Invasive Prenatal Diagnosis for Single Gene Disorders
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06147414Effects of Photobiomodulation in Hemophilia Patients.
NA · 1 location(s) · Riphah International University · NCT07579585Nuwiq for Perioperative Management Of Patients With Haemophilia A on Emicizumab Regular Prophylaxis Study
Phase 4 · 18 location(s) · Octapharma · NCT05935358Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B R
Phase 3 · 23 location(s) · Pfizer · NCT05568719Adult and Adolescent Hemophilia Patients Treated With Marstacimab: a Patient Experience Registry
Phase N/A · 2 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT06992076Liver Biopsy In Haemophilia Gene Therapy
NA · 1 location(s) · University College, London · NCT04817462Manual Therapy in Hemophilic Arthropathy of the Ankle
NA · 1 location(s) · Investigación en Hemofilia y Fisioterapia · NCT06816056The CACHE Study: Coronary Artery Care in HaEmophilia
Phase N/A · 1 location(s) · Oxford University Hospitals NHS Trust · NCT06706206Embolization in Hereditary Coagulopathies
NA · 1 location(s) · University of Sao Paulo General Hospital · NCT05629130A Research Study Looking at How Different Doses of Study Medicine (Inno8) Work in the Body of People With Haemophilia A
Phase 1 · 33 location(s) · Novo Nordisk A/S · NCT07220564A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SR604 in Two Participants Groups (Part A: Hea
Phase 1 · 10 location(s) · Equilibra Bioscience LLC · NCT06349473SAFE Study: Safety of aPCC Following Emicizumab Prophylaxis
Phase 3 · 2 location(s) · Emory University · NCT04563520To Evaluate the Clinical Study of GS1191-0445 Injection in the Treatment of Hemophilia A
Phase 3 · 13 location(s) · Gritgen Therapeutics Co., Ltd. · NCT06833983Longitudinal Cohort of Thrombosis and Hemostasis Diseases
Phase N/A · 5 location(s) · Peking University People's Hospital · NCT06727669High-Altitude Hematology Observation-Stem Cell Transplantation (HALO-SCT)
Phase N/A · 1 location(s) · Yigeng Cao,MD,PhD · NCT07205523A Gene Therapy Study of SPK-8011QQ in Adults With Severe or Moderately Severe Hemophilia A
Phase 1/Phase 2 · 2 location(s) · Hoffmann-La Roche · NCT07226206A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Year
Phase 3 · 30 location(s) · Sanofi · NCT07285460Assessing Different FVIII Doses and Frequencies in Immune Tolerance Induction (ITI) with ADVATE Among Hemophilia a Boys
Phase 4 · 1 location(s) · Runhui WU · NCT06864975Long-term Anticoagulation in a Patient With Severe Hemophilia A
Phase N/A · 1 location(s) · University Hospital, Strasbourg, France · NCT07314983The European Paediatric Network for Haemophilia Management ( PedNet Registry)
Phase N/A · 39 location(s) · PedNet Haemophilia Research Foundation · NCT02979119
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.